Citing a lack of longitudinal data on the No Surprises Act, major health plans have cautiously paused emergency care payouts to assess the potential toxicity of compliance.
Experts caution that while the federal law was intended to end surprise medical bills, its implementation has been strongly associated with high-dollar payouts to physicians. In response to this acute financial symptom, providers like UnitedHealthcare and Cigna have initiated a strict withholding protocol, pending further peer-reviewed evidence that the law actually applies to them.
"While preliminary data indicates these withheld payments may be in direct violation of consumer statutes, we must remember that correlation does not equal causation," read a joint statement from the insurance cohort. "More research is needed to understand whether ignoring emergency claims produces adverse regulatory events, or if it is generally well-tolerated by our shareholders."
A recent retrospective analysis published in a JAMA paper noted that paying for emergency room visits remains a significant risk factor for reduced profit margins. However, study authors emphasized that the sample size of insurers currently obeying the law was far too small to draw definitive conclusions.
Though self-reported physician data suggests millions of dollars are currently missing, we cannot definitively rule out the possibility that the funds are simply experiencing a delayed physiological response.
Until the NIH issues definitive guidance on the safe dosage of federal compliance, industry analysts recommend that insurers maintain a conservative posture of blanket denials. Patients experiencing a severe medical emergency are advised to monitor their symptoms and avoid seeking out-of-network care unless they are prepared to participate in a double-blind billing dispute.